from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1361c/PPE19

LFCtreatmentdescriptionclass of inhibitor

0.043

Amikacinug/mL Amikacintranslation

-0.077

Cap5-10ug/mL Capreomycintranslation

0.118

Rox10-50 ug/mL Roxithromycintranslation

-0.021

SM2-5 ug/mL Streptomycintranslation

-0.333

Tet5-10 ug/mL Tetracyclinetranslation

-0.586

Rif0.2-5ug/mL Rifampicintranscription

-0.548

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.041

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.082

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.354

CPZ10-50 ug/mL Chlorpromazinerespiration

0.108

Clofazimine10-13 ug/mL Clofaziminerespiration

0.450

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.832

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.360

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.202

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.325

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.773

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.282

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.701

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.258

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.635

KCN5-20 ug/mL Potassium cyaniderespiration

0.241

NaN30.2-2 mM Sodium aziderespiration

0.661

Nigericin50 uM Nigericinrespiration

-1.599

TRC10-150 ug/mL Triclosanrespiration

-0.943

TRZ10-25 ug/mL Thioridazinerespiration

1.365

Valinomycin0.5-10 uM Valinomycinrespiration

0.364

ZnSO42 mM ZnSO4respiration

-0.270

menadione6-10 ug/mL Menadionerespiration

0.504

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.377

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.363

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.507

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.017

NRP_1Non-replicating persistence stage 1dosRassociated

0.460

Amp0.2mg/mL AmpicillincellWall

0.578

Cephalexin20-100 ug/mL CephalexincellWall

-0.253

Cerulenin0.32-5 ug/mL CerulenincellWall

0.860

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.816

EMB10-20 ug/mL EthambutolcellWall

0.455

Eta12-40 ug/mL EthionamidecellWall

0.674

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.685

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.301

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.971

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.520

BZA0.12 mg/mL BenzamidearomaticAmides

-0.367

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.054

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.066

H2O24 mM hydrogen peroxideDNAdamaging

-0.026

Levo10 ug/mL LevofloxacinDNAdamaging

0.303

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.430

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.083

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.661

UVUV-irradiationDNAdamaging

-1.602

ARP41-4 ug/mL Antitubercular compound ARP4?

0.206

Antimycin12.5-50 ug/mL Antimycin A?

0.400

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.147

PA_110-50 ug/mL Antitubercular compound PA-1?

0.221

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.852

PA8240.2-2 ug/mL PA-824?

-1.179

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.067

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.550

Verapamil50 uM Verapamil?

0.698

mercaptoethanol2 mM 2-Mercaptoethanol?

0.792

methoxatin10-20 ug/mL Methoxatin?